Triple agonism introduces hepatic glucagon receptor activation effects absent in both semaglutide and tirzepatide protocols, including differential modulation of hepatic glucose output and adipose fatty acid oxidation
This compound is supplied strictly for research and analytical purposes and is not intended for human or veterinary use
Effects felt within 2472 hours of first injection
AOD-9604 hasdemonstratedpotent lipolytic activity without impacting glucose levels, tissue growth, or inducing overeating
Speaking to a Healthcare Professional Before Use Patients should consult a GP, pharmacist, or obesity specialist before using any unlicensed peptide
Whether youre prepping for an event, struggling with stubborn fat, or looking to reclaim your body after 30 AOD-9604 at Revital Trichology offers a safe, science-backed solution